Prognostic Value of Conization and Negative HPV After Conization in AIS and Early Stage Ce
In women with cervical cancer -Squamous cell carcinoma, Adeno carcinoma, Adeno-squamous carcinoma or AIS we want to examine prospectively: 1. Examine if negative HR-HPV after conization to the HR-HPV the women had before conization has a high prognostic value for no residual tumor in the final pathology. 2. To examine
| Condition(s) | Cervix Cancer, HPV-Related Malignancy |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | In women with cervical cancer -Squamous cell carcinoma, Adeno carcinoma, Adeno-squamous carcinoma or AIS we want to examine prospectively: 1. Examine if negative HR-HPV after conization to the HR-HPV the women had before conization has a high prognostic value for no residual tumor in the final pathology. 2. To examine if conization in women with cervical tumor up to Stage I B 2 (FIGO 2018) is corelated with better prognosis. |
| Who can participate | Inclusion Criteria: Age Range: 18-85 years old Cervical cancer stage I B 2(Tumor up to 4 cm FIGO 2018) AIS HPV types before and after conization Exclusion Criteria: Pregnant women under 18 years old. Women who refused to continue to be in study. Women that data about HPV types , final pathology or complication are missing. |
| Ages | 18 Years to 85 Years |
| Sex | Female |
| Lead sponsor | Rambam Health Care Campus |
| Locations | Haifa, Israel |
| Start date | 2023-07-26 |
| NCT ID | NCT06196190 |
| Official listing | https://clinicaltrials.gov/study/NCT06196190 |